Le Lézard
Classified in: Health
Subject: MISCELLANEOUS

Altasciences' Chris Perkin Honored as One of 100 Most Inspiring Leaders  in the Life Sciences Industry


LAVAL, Quebec, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Altasciences, a leading North American early phase contract research organization (CRO), is pleased to announce that, for a fourth consecutive year, CEO Chris Perkin has been honored as one of the 100 Most Inspiring Leaders in the Life Sciences Industry by PharmaVOICE magazine. Chris is again recognized for the positive impact he has had on the drug development industry through his leadership, influence and positive actions. 

Chris has more than 40 years' experience, initially as a scientist and subsequently as a strategic leader, in the CRO industry. He joined Altasciences in 2010, and the Company continues to flourish under his direction. His ongoing guidance, dedication, and innovative drive to excel led to this fourth consecutive nomination by his peers and employees. He is an inspirational corporate leader whose acumen and ability to develop breakthrough strategies ensure the continued success of Altasciences.

Chosen from among thousands of nominations to the PharmaVOICE 100, Chris was humbled by his fourth consecutive award. He said "I'm honored to be recognized by the people I work most closely with, my colleagues and peers. I share this recognition with them; it is their dedication and scientific excellence that drive the success of our company. Together, we achieve more; we accelerate growth and continue to reach new heights."

About Altasciences
Altasciences is a mid-size contract research organization that encompasses Algorithme Pharma in Montreal, QC, Vince & Associates Clinical Research in Overland Park, KS, and Algorithme Pharma USA in Fargo, ND, with an overall company focus on supporting early-stage drug development. With over 25 years of industry experience, Altasciences provides clinical services to an international customer base of biopharmaceutical companies. Altasciences' full-service solutions offering in this critical stage of drug development includes clinical pharmacology, medical writing, biostatistics, data management and bioanalysis.

FOR MORE INFORMATION
Julie-Ann Cabana
[email protected]
913 304-4505


These press releases may also interest you

at 15:25
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...

at 11:55
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from a real-world patient cohort review of JELMYTO...

at 09:00
Women's Heart Health Month is recognized every May and is focused on raising awareness about cardiovascular health among women. It aims to educate women about the risks, symptoms, and prevention of heart disease, which is the leading cause of death...

at 07:56
RaySearch Laboratories AB (publ) and C-RAD are pleased to announce a collaboration agreement, aiming at jointly developing innovative solutions and products to enhance the quality of radiation therapy. The focus of the collaboration is to...

at 06:00
SecondOpinionExpert, Inc. (SOE), a leading healthcare technology company, announced today that OC Fertility® + OC Biogenix® located in Newport Beach, Orange County, California will join SOE's expert panel to provide second opinions for fertility...

at 05:00
Scientology Network's VOICES FOR HUMANITY, the weekly series presenting heroic change makers from a variety of faiths, cultures and nations, working to uplift their communities, announces a new episode featuring anti-drug activist Robert Galibert....



News published on and distributed by: